Guardian Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Guardian Partners's PFE Position: Q3 2026 in Review
Guardian Partners increased its Pfizer (PFE) stake by 44% in Q3 2026, buying an estimated $549K and bringing the position to 67,455 shares worth $1.92M. The position accounts for 0.17% of the portfolio, ranked #93.
Guardian Partners first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.46M in Q4 2024. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Guardian Partners held 67,455 shares of Pfizer worth $1.92M as of Q3 2026.
- Guardian Partners bought 20,645 Pfizer shares in Q3 2026, an estimated $549K.
- Pfizer made up 0.17% of Guardian Partners's portfolio in Q3 2026, its #93 holding.
- Guardian Partners first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
- Guardian Partners's Pfizer position peaked at $3.46M in Q4 2024.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Guardian Partners's 13F filing for Q3 2026, filed 21 Oct 2026.